Stephan Stern

Company: Frederick National Laboratory for Cancer Research

Job title: Director, Research & Development, Nanotechnology Characterization Lab, Cancer Research Technology Program

Seminars:

Novel Bioanalytical Methods to Determine LNP Biodistribution & Stability 11:30 am

Determination of lipid nanoparticle (LNP) pharmacokinetics is important for understanding targeted and off-target distribution, but has been limited by the lack of generally applicable, bioanalytical methods We have recently developed a novel bioanalytical method to quantify DSPC, a common lipid component lipidic formulations, including LNPs This presentation will showcase DSPC pharmacokinetic data for multiple lipidic…Read more

day: Conference Day Two